Typical and atypical antipsychotic drugs target dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa and neurotensin-containing neurons, but not GABAergic interneurons in the shell of nucleus accumbens of ventral striatum

Neuroscience

Volumn 141, Issue 3, 2006, Pages 1469-1480

  Ma, J ^a,b   Ye, N ^a,b   Cohen, B M ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

clozapine; Fos; haloperidol; projection neurons; schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ATYPICAL ANTIPSYCHOTIC AGENT; CALBINDIN; CALCIUM BINDING PROTEIN; CALRETININ; CLOZAPINE; CYCLIC AMP; DOPAMINE; HALOPERIDOL; NEUROLEPTIC AGENT; NEUROPEPTIDE; NEUROTENSIN; NEUROTRANSMITTER; PARVALBUMIN; PHOSPHOPROTEIN; PROTEIN FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CELL ACTIVATION; CELL SUBPOPULATION; CELL TYPE; CONTROLLED STUDY; CORPUS STRIATUM; IMMUNOFLUORESCENCE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN;

ANIMALS; ANTIPSYCHOTIC AGENTS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL COUNT; CLOZAPINE; DOPAMINE; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HALOPERIDOL; MALE; NEURONS; NEUROTENSIN; NUCLEUS ACCUMBENS; PARVALBUMINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33746420067     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.05.013     Document Type: Article

References (71)

1. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney Jr. W.E., and Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52 (1995) 258-266
2. Arnt J. Do novel antipsychotics have similar pharmacological characteristics?. Neuropsychopharmacology 18 (1998) 63-101
3. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., and Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 48 (1991) 996-1001
4. Benes F.M., Vincent S.L., Alsterberg G., Bird E.D., and SanGiovanni J.P. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 12 (1992) 924-929
5. Binder E.B., Kinkead B., Owens M.J., and Nemeroff C.B. Neurotensin and dopamine interactions. Pharmacol Rev 53 (2001) 453-486
6. Binder E.B., Kinkead B., Owens M.J., and Nemeroff C.B. The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs. Biol Psychiatry 50 (2001) 856-872
7. Blum B.P., and Mann J.J. The GABAergic system in schizophrenia. Int J Neuropharmacol 5 (2002) 159-179
8. Brooks K.M., Cai J., Sandrasagra A., Roehr J.E., Errazo R., and Vargas H.M. Interaction of clozapine and other antipsychotic drugs with human alpha 1-adrenergic receptor subtypes. Proc West Pharmacol Soc 42 (1999) 67-69
9. Chang H.T., and Kitai S.T. Projection neurons of the nucleus accumbens. an intracellular labeling study. Brain Res 347 (1985) 112-116
10. Cohen B.M., Wan W., Froimowitz M.P., Ennulat D.J., Cherkerzian S., and Konieczna H. Activation of midline thalamic nuclei by antipsychotic drugs. Psychopharmacology 135 (1998) 37-43
11. Cohen B.M., Cherkerzian S., Ma J., Ye N., and Lange N. Cells in central amygdala, midline thalamus and nucleus accumbens respond specifically to antipsychotic drugs. Psychopharmacology 167 (2003) 403-410
12. Cowan R.L., Wilson C.J., Emson P.C., and Heizmann C.W. Parvalbumin-containing GABAergic interneurons in the rat neostriatum. J Comp Neurol 302 (1990) 197-205
13. Decker K.P., Roy-Byrne P.P., and Merchant K.M. Effect of muscimol on haloperidol-induced alteration of neurotensin gene expression in the striatum and nucleus accumbens in the rat. Brain Res 691 (1995) 9-17
14. Deutch A.Y., Clark W.A., and Roth R.H. Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res 521 (1990) 311-315
15. Deutch A.Y., Lee M.C., and Ladarola M. Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression. the nucleus accumbens shell as a locus of antipsychotic action. Mol Cell Neurosci 3 (1992) 332-341
16. Eggerman K.W., and Zahm D.S. Numbers of neurotensin-immunoreactive neurons selectively increased in rat ventral striatum following acute haloperidol administration. Neuropeptides 11 (1988) 125-132
17. Fienberg A.A., Hiroi N., Mermelstein P.G., Song W., Snyder G.L., Nishi A., Cheramy A., O'Callaghan J.P., Miller D.B., Cole D.G., Corbett R., Haile C.N., Cooper D.C., Onn S.P., Grace A.A., Ouimet C.C., White F.J., Hyman S.E., Surmeier D.J., Girault J., Nestler E.J., and Greengard P. DARPP-32. regulator of the efficacy of dopaminergic neurotransmission. Science 281 (1998) 838-842
18. Greengard P., Nairn A.C., Girault J.A., Ouimet C.C., Snyder G.L., Fisone G., Allen P.B., Fienberg A., and Nishi A. The DARPP-32/protein phosphatase-1 cascade. a model for signal integration. Brain Res Brain Res Rev 26 (1998) 274-284
19. Greengard P. The neurobiology of dopamine signaling. Biosci Rep 21 (2001) 247-268
20. Griffiths M.R., Mitchell I.J., and Cooper A.J. Phencyclidine induces D-1 dopamine receptor mediated Fos-like immunoreactivity in discretely localised populations of striatopallidal and striatoentopeduncular neurons in the rat. Brain Res 821 (1999) 177-189
21. Groenewegen H.J., Wright C.I., Beijer A.V., and Voorn P. Convergence and segregation of ventral striatal inputs and outputs. Ann N Y Acad Sci 877 (1999) 49-63
22. Guo N., Vincent S.R., and Fibiger H.C. Phenotypic characterization of neuroleptic-sensitive neurons in the forebrain. contrasting targets of haloperidol and clozapine. Neuropsychopharmacology 19 (1998) 133-145
23. Gustafson E.L., Ouimet C.C., and Greengard P. Spatial relationship of the striatonigral and mesostriatal pathways. double-label immunocytochemistry for DARPP-32 and tyrosine hydroxylase. Brain Res 491 (1989) 297-306
24. Heimer L., Zahm D.S., Churchill L., Kalivas P.W., and Wohltmann C. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 41 (1991) 89-125
25. Hiroi N., and Graybiel A.M. Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum. J Comp Neurol 374 (1996) 70-83
26. Hökfelt T., Everitt B.J., Theodorsson-Norheim E., and Goldstein M. Occurrence of neurotensinlike immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons. J Comp Neurol 222 (1984) 534-559
27. Jennes L., Stumpf W.E., and Kalivas P.W. Neurotensin. topographical distribution in rat brain by immunohistochemistry. J Comp Neurol 210 (1982) 211-224
28. Kawaguchi Y., Wilson C., Augood S., and Emson P. Striatal interneurons. chemical, physiological and morphological characterization. Trends Neurosci 18 (1995) 527-535
29. Keith D.A., and Reiner A. Immunohistochemical localization of DARPP-32 in striatal projection neurons and striatal interneurons. implications for the localization of D 1-like dopamine receptors on different types of striatal neurons. Brain Res 568 (1991) 235-243
30. Kinkead B., Binder E.B., and Nemeroff C.B. Does neurotensin mediate the effects of antipsychotic drugs?. Biol Psychiatry 46 (1999) 340-351
31. Kinkead B., and Nemeroff C.B. Neurotensin, schizophrenia, and antipsychotic drug action. Int Rev Neurobiol 59 (2004) 327-349
32. Kubota Y., and Kawaguchi Y. Dependence of GABAergic synaptic areas on the interneurons type and target size. J Neurosci 20 (2000) 375-386
33. Lenz S., Perney T.M., Qin Y., Robbins E., and Chesselet M.F. GABA-ergic interneurons of the striatum express the Shaw-like potassium channel Kv3.1. Synapse 18 (1994) 55-66
34. Ma J., Ye N., Lange N., and Cohen B.M. Dynorphinergic GABA neurons are a target of both typical and atypical antipsychotic drugs in the nucleus accumbens shell, central amygdaloid nucleus and midline thalamic central medial nucleus. Neuroscience 121 (2003) 991-998
35. Ma J., Ye N., and Cohen B.M. Expression of noradrenergic Alpha 1, dopaminergic and serotoninergic receptors selectively express in antipsychotic drug-activated neurons in the shell of nucleus accumbens, central amygdaloid and midline thalamic central nucleus. Prog Neuron Psychopharmacol Biol Psychiatry 30 (2006) 647-657
36. Meador-Woodruff J.H., Hogg A.J., and Smith R.E. Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder. Brain Res Bull 55 (2001) 631-640
37. Merchant K.M., Dobie D.J., and Dorsa D.M. Expression of the proneurotensin gene in the rat brain and its regulation by antipsychotic drugs. Ann N Y Acad Sci 668 (1992) 54-69
38. Merchant K.M., Dobner P.R., and Dorsa D.M. Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum. J Neurosci 12 (1992) 652-663
39. Merchant K.M., and Dorsa D.M. Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics. Proc Natl Acad Sci U S A 90 (1993) 3447-3451
40. Merchant K.M., and Miller M.A. Coexpression of neurotensin and c-fos mRNAs in rat neostriatal neurons following acute haloperidol. Mol Brain Res 23 (1994) 271-277
41. Meredith G., Agolia R., Arts M., Groenewegen H., and Zahm D.S. Morphological differences between projection neurons of the core and shell in the nucleus accumbens of the rat. Neuroscience 50 (1992) 149-192
42. Meredith G.E., Ypma P., and Zahm D.S. Effects of dopamine depletion on the morphology of medium spiny neurons in the shell and core of the rat nucleus accumbens. J Neurosci 15 (1995) 3808-3820
43. Meredith G.E. The synaptic framework for chemical signaling in nucleus accumbens. Ann N Y Acad Sci 877 (1999) 140-156
44. Nguyen T.V., Kosofsky B.E., Birnbaum R., Cohen B.M., and Hyman S.E. Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc Natl Acad Sci U S A 89 (1992) 4270-4274
45. Ouimet C.C., Miller P.E., Hemmings H.C.J., Walaas S., and Greengard P. DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J Neurosci 4 (1984) 111-124
46. Peroutka S.J., and Synder S.H. Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 137 (1980) 1518-1522
47. Perry T.L., Kish S.J., Buchanan J., and Hansen S. Gamma-aminobutyric-acid deficiency in brain of schizophrenic patients. Lancet 1 (1979) 237-239
48. Powell E.W., and Leman R.B. Connections of the nucleus accumbens. Brain Res 105 (1976) 389-403
49. Prensa L., Richard S., and Parent A. Chemical anatomy of the human ventral striatum and adjacent basal forebrain structures. J Comp Neurol 460 (2003) 345-367
50. Robertson G.S., and Fibiger H.C. Neuroleptics increase c-fos expression in the forebrain. contrasting effects of haloperidol and clozapine. Neuroscience 46 (1992) 315-328
51. Robertson G.S., Matsumura H., and Fibiger H.C. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther 271 (1994) 1058-1066
52. Rostene W., Azzi M., Boudin H., Lepee I., Souaze F., Mendez-Ubach M., Betancur C., and Gully D. Use of nonpeptide antagonists to explore the physiological roles of neurotensin. Focus on brain neurotensin/dopamine interactions. Ann N Y Acad Sci 814 (1997) 125-141
53. Roth B.L., Sheffler D.J., and Kroeze W.K. Magic shotguns versus magic bullets. selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 3 (2004) 353-359
54. Semba J., Sakai M.W., Suhara T., and Akanuma N. Differential effects of acute and chronic treatment with typical and atypical neuroleptics on c-fos mRNA expression in rat forebrain regions using non-radioactive in situ hybridization. Neurochem Int 34 (1999) 269-277
55. Setlow B. The nucleus accumbens and learning and memory. J Neurosci Res 49 (1997) 515-521
56. Simpson M.D., Slater P., Deakin J.F., Royston M.C., and Skan W.J. Reduced GABA uptake sites in the temporal lobe in schizophrenia. Neurosci Lett 107 (1989) 211-215
57. Skogh C., Parmar M., and Campbell K. The differentiation potential of precursor cells from the mouse lateral ganglionic eminence is restricted by in vitro expansion. Neuroscience 120 (2003) 379-385
58. Solbach S., and Celio M.R. Ontogeny of the calcium binding protein parvalbumin in the rat nervous system. Anat Embryol 184 (1991) 103-124
59. Sugimoto T., and Mizuno N. Neurotensin in projection neurons of the striatum and nucleus accumbens, with reference to coexistence with enkephalin and GABA. an immunohistochemical study in the cat. J Comp Neurol 257 (1987) 383-395
60. Svenningsson P., Fienberg A.A., Allen P.B., Moine C.L., Lindskog M., Fisone G., Greengard P., and Fredholm B.B. Dopamine D (1) receptor-induced gene transcription is modulated by DARPP-32. J Neurochem 75 (2000) 248-257
61. Svenningsson P., Tzavara E.T., Carruthers R., Rachleff I., Wattler S., Nehls M., Mckinzie D.L., Fienber A.A., Nomikos G.G., and Greengard P. Diverse psychotomimetics act through a common signaling pathway. Science 302 (2003) 1412-1415
62. Swanson S.L. Brain maps. structure of the brain rat. 2nd edition. (1998), Elsevier Science B V Press, Amsterdam, The Netherlands
63. Thomas M.J., Beurrier C., Bonci A., and Malenka R.C. Long-term depression in the nucleus accumbens. a neural correlate of behavioral sensitization to cocaine. Nat Neurosci 4 (2001) 1217-1223
64. Walaas S.I., and Ouimet C.C. The ventral striatopallidal complex. an immunocytochemical analysis of medium-sized striatal neurons and striatopallidal fibers in the basal forebrain of the rat. Neuroscience 28 (1989) 663-672
65. Wan W., Ennulat D.J., and Cohen B.M. Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain. Brain Res 688 (1995) 95-104
66. Werme M., Ringholm A., Olson L., and Brene S. Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine. Brain Res 863 (2000) 112-119
67. Whittington M.A., and Traub R.D. Interneuron diversity series. inhibitory interneurons and network oscillations in vitro. Trends Neurosci 26 (2003) 676-682
68. Zahm D.S., Williams E.S., Poulad D., and Krause J.E. Temporal dissociation of neurotensin/neuromedin N mRNA expression in topographically separate subsets of rat striatal neurons following administration of haloperidol. Brain Res Mol Brain Res 42 (1996) 71-78
69. Zahm D.S., Williams E.S., Krause J.E., Welch M.A., and Grosu D.S. Distinct and interactive effects of D-amphetamine and haloperidol on levels of neurotensin and its mRNA in subterritories in the dorsal and ventral striatum of the rat. J Comp Neurol 400 (1998) 487-503
70. Zahm D.S. An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens. Neurosci Biobehav Rev 24 (2000) 85-105
71. Zhou L., Furuta T., and Kaneko T. Chemical organization of projection neurons in the rat accumbens nucleus and olfactory tubercle. Neuroscience 120 (2003) 783-789